Dissemination
The latest news, publications and events from the ERAMET consortium.
The study of monoclonal antibodies for moderate-to-severe asthma examines how modelling and simulation have supported their development and regula…
A review of six authorised CAR-T therapies examines how modelling and simulation have supported their development and regulatory approval in Europe…
An ERAMET-supported review examines how modelling and simulation are used in medicine development for sickle cell disease and thalassaemia. Drawing…
A five-year review of EMA Scientific Advice explores how concentration-QT modelling can support cardiac safety assessments and requests to waive de…
A recent study comparing SIMCYP and PK-Sim shows how differences between modelling platforms can lead to clinically relevant variations in predicte…
A new study explores how modelling and simulation can support the development of antibiotics for children using ceftriaxone as a case study to hig…
ERAMET will contribute to the TEDDY General Assembly and Scientific Meeting 2026 through a dedicated panel on how innovative methodologies can stre…
A new publication in Clinical Pharmacology & Therapeutics highlights how innovative model-informed approaches can support more efficient evidence g…
The University of Catania is pleased to announce the opening of applications for its new International PhD Programme in Pharmaceutical Sciences, a …
Francesco Pappalardo, from the University of Catania, presented ERAMET as a concrete example of an ecosystem supporting pediatric rare disease rese…
From 14-16 April, the ERAMET team gathered in Catania, Italy, for a productive face-to-face meeting, bringing together consortium members to review…
We are pleased to announce our upcoming Open Day, which will take place on April 15 during the upcoming Face-to-Face meeting. The event will bring …
